Given that the EV marker expression of CD63 in tumour tissues using immunohistochemistry has been shown to be feasible (23), we examined the expression patterns of CD63 staining in a tissue microarray (TMA) of early BC patients (n = 218) (Figure 1G). The gene discussed is CD63; the disease is breast cancer.